HighBar Partners, a Menlo Park, CA-based private equity investor, acquired SilkRoad Technology, a global software and cloud-based technology platform designed to increase employee satisfaction and productivity. Debt financing for the transaction was provided by Bridge Bank.
Bessemer Investors, a New York-based investment firm, acquired a stake in Legacy Restoration, a provider of exterior restoration and remodeling services. Tree Line Capital Partners and Bridge Bank, a division of Western Alliance Bank, provided debt financing for the transaction.
Bridge Bank’s Boston-based technology banking group extended a $5 million monthly recurring revenue line of credit to One Medical Passport, a provider of software that helps ambulatory surgery centers and hospitals streamline their systems.
Bridge Bank’s East Bay commercial and industrial banking group extended a $2.5 million credit facility to NORCAL Ambulance, a specialty-care transport company administratively based in Livermore, CA, with stations throughout Northern California.
Fennec Pharmaceuticals, a specialty pharmaceutical company, amended its existing senior debt facility with the life sciences group at Bridge Bank, increasing the size of the facility from $18 million to $20 million.
Bridge Bank closed a $25 million credit facility with Targeted Lease Capital, a Williamsville, NY-based company that provides equipment finance loans to small businesses.
Bridge Bank’s technology banking group extended a $15 million growth capital term loan to Examity, a technology company concentrating on the online proctoring market.
Tree Line Capital Partners served as last-out lender for a first lien credit facility to support Alianza’s acquisition of CounterPath. Bridge Bank served as administrative agent and provided a first-out term loan and revolver to support the transaction.
Bridge Bank hired Nick Nardulli as assistant vice president of portfolio management, Richard Biers as vice president of portfolio management and Steven Ogus as senior vice president of asset-based lending, all in the company’s capital finance group.
Bridge Bank provided a new $15 million term loan for CytoSorbents Corporation after the company repaid the outstanding principal balance of its existing $15 million term loan with the bank.